AstraZeneca Coronavirus Vaccine Trials Remain Stalled In The U.S.
Tests were halted after two participants experienced potentially serious side effects.
A coronavirus vaccine trial in the U.S. is still on hold.
AstraZeneca released its trial blueprint Saturday detailing how its potential vaccine is being tested.
The company said the trials remain stalled in the U.S. but have resumed in Britain, Brazil, India and South Africa.
Tests were halted after two participants experienced potentially serious neurological side effects. The company and U.K. regulators said the second case was not linked to the virus. The FDA has not commented on when or if it will allow trials to continue in the U.S.
Long COVID patients use experimental shot for sense of smell issues
People are traveling from around the world to a Texas center that is testing a pain medication injection as a way to treat loss of smell from COVID.By Scripps News
Why COVID vaccine outreach is still critical in 2023
Pharmacists are working to get the COVID vaccine to communities that may not have easy access to a pharmacy.By Scripps News
US proposes once-a-year COVID shots for most Americans
The FDA proposed a simplified approach for future vaccination efforts, allowing most adults and children to get a once-a-year shot to combat COVID.By Rogelio V. Solis / AP
Police say 3 dead, 4 hurt in latest California shooting
This marks the fourth mass shooting in California this month.By Matt Rourke / AP
FDA moves to ease rules for blood donations from gay men
The FDA announced draft guidelines that would do away with the three-month abstinence requirement for donations from men who have sex with men.By Francois Mori / AP
'I could have been dead': Connor McGregor hit by car while riding bike
McGregor claimed that a driver was blinded by the sun when he crashed into him.By Evan Agostini / Invision via AP